Clinical Ophthalmology (Apr 2021)
Macular Vessel Density in Diabetic Retinopathy Patients: How Can We Accurately Measure and What Can It Tell Us?
Abstract
Varsha Pramil,1,2 Emily S Levine,1,2 Nadia K Waheed1 1New England Eye Center, Tufts Medical Center, Boston, MA, USA; 2Tufts University School of Medicine, Boston, MA, USACorrespondence: Nadia K WaheedNew England Eye Center, Tufts Medical Center, 260 Tremont St., Boston, MA, 02116, USATel +1 617-636-4600Fax +1 617-636-4866Email [email protected]: Diabetic retinopathy is one of the leading causes of blindness worldwide. Optical coherence tomography angiography (OCTA) is a non-invasive technology that provides depth-resolved images of the chorioretinal vasculature and allows for the understanding of the changes in vasculature with diabetic retinopathy. Not only can it provide qualitative information, but OCTA can also provide quantitative information about the vasculature in patients with diabetic retinopathy. Macular vessel density is one of the quantitative metrics that can be obtained from OCTA images. This is a repeatable and non-subjective measurement that can provide valuable insight into the pathophysiology of diabetic retinopathy. In this non-systematic review, the measurement of macular vessel density in diabetic retinopathy and the reasons for its importance in the diagnosis and management of patients with diabetes and varying severities of diabetic retinopathy is discussed.Keywords: diabetic retinopathy, macular vessel density, OCTA
